MedTrace Logo

Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia

NCT02464930 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2015-06-08

No results posted yet for this study

Summary

The primary purpose of this study is to test new methods to diagnose BE in time before it turns into advanced cancer. Once BE is diagnosed, the current standard of care is to monitor the disease so that complication such as cancer can be diagnosed early. The two new methods the investigators are evaluating are: a) blood test and b) brush test of the food pipe. The investigators will collect blood, bile and cells from the food pipe and stomach and measure for a biomarker called microRNA (miRNA). In the future, measurements of microRNA biomarkers could help the doctors figure out which patients are at increased risk for cancer of the esophagus.

Conditions

  • Barrett's Esophagus
  • Gastroesophageal Reflux
  • Esophageal Adenocarcinoma

Sponsors & Collaborators

  • Kansas City Veteran Affairs Medical Center

    collaborator FED

  • University of Kansas

    collaborator OTHER

  • Midwest Biomedical Research Foundation

    lead OTHER

Principal Investigators

  • Ajay Bansal, MD · Veterans Affairs Medical Center and the University of Kansas Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-04-30
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02464930 on ClinicalTrials.gov